Submitted by: Submitted by vasu123
Views: 10
Words: 1085
Pages: 5
Category: Business and Industry
Date Submitted: 03/14/2016 12:06 AM
France Clinical Chemistry Market Size, Share, Global Trends, Company
Profiles, Demand, Insights, Analysis, Research, Report, Opportunities,
Segmentation and Forecast To 2021
Summary
GlobalData's new report, "France Clinical Chemistry Market Outlook to 2021", provides key
market data on the France Clinical Chemistry market. The report provides value, in millions of
US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid
Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite
Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.
The report also provides company shares and distribution shares data for the market category,
and global corporate-level profiles of the key market participants. Based on the availability of
data for the particular category and country, information related to pipeline products, news and
deals is available in the report.
Read Complete Report with TOC: http://www.radiantinsights.com/research/franceclinical-chemistry-market-outlook-to-2021
Extensive interviews are conducted with industry experts to validate the market size, company
share and distribution share data and analysis.
Scope
- Clinical Chemistry market includes Clinical Chemistry Analyzers, Clinical Chemistry Rapid
Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite
Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.
- Annualized market revenues (USD million) data for each of the market categories. Data is
provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Clinical Chemistry market.
- Global corporate-level profiles of key companies operating within the France Clinical
Chemistry market.
- Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche
Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad
Laboratories, Inc.
Reasons to buy
- Develop...